TickerFacts.

Vertex Pharmaceuticals Inc (VRTX): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2012-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

258.00M
Year ended 2025-12-31
-0.1%
3-year compound annual growth
-0.4%
5-year compound annual growth
+0.7%
10-year compound annual growth
263.40M2008-12-31: 140.56M2009-12-31: 173.26M2010-12-31: 200.40M2011-12-31: 208.81M2012-12-31: 215.26M2013-12-31: 224.91M2014-12-31: 235.31M2015-12-31: 241.31M2016-12-31: 244.69M2017-12-31: 253.22M2018-12-31: 259.19M2019-12-31: 260.70M2020-12-31: 263.40M2021-12-31: 259.90M2022-12-31: 259.10M2023-12-31: 260.50M2024-12-31: 257.90M2025-12-31: 258.00M258.00M
2008-12-31 Weighted Average Diluted Shares (shares) 2025-12-31
Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-31258.00M0.0%2026-02-13, From 2025-01-01
2024-12-31257.90M-1.0%2026-02-13, From 2024-01-01
2023-12-31260.50M+0.5%2026-02-13, From 2023-01-01
2022-12-31259.10M-0.3%2025-02-13, From 2022-01-01
2021-12-31259.90M-1.3%2024-02-15, From 2021-01-01
2020-12-31263.40M+1.0%2023-02-10, From 2020-01-01
2019-12-31260.70M+0.6%2022-02-09, From 2019-01-01
2018-12-31259.19M+2.4%2021-02-11, From 2018-01-01
2017-12-31253.22M+3.5%2020-02-13, From 2017-01-01
2016-12-31244.69M+1.4%2019-02-13, From 2016-01-01
2015-12-31241.31M+2.6%2018-02-15, From 2015-01-01
2014-12-31235.31M+4.6%2017-02-23, From 2014-01-01
2013-12-31224.91M+4.5%2016-02-16, From 2013-01-01
2012-12-31215.26Mn/c2015-02-13, From 2012-01-01
2011-12-31208.81M+4.2%2014-02-11, From 2011-01-01
2010-12-31200.40M+15.7%2013-03-01, From 2010-01-01
2009-12-31173.26M+23.3%2012-02-22, From 2009-01-01
2008-12-31140.56Mn/a2011-02-17, From 2008-01-01